Concepedia

Rom E. Eliaz

RE

10

Publications

914

Citations

10

H-Index

1996

Active since

Affiliations

Ben-Gurion University of the Negev(Current)

University of California, San Francisco

Teva Pharmaceuticals (Israel)

Weizmann Institute of Science

Rom E. Eliaz is an author at Ben-Gurion University of the Negev specializing in medicine, biomedical engineering, and engineering.

Top concepts

Publications per year

1996–2016

10

Publications

10

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Rom E. Eliaz, Francis C. Szoka · PubMed · 2001 · 330 citations

, , +17

Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins

Rom E. Eliaz, Joseph Kost · Journal of Biomedical Materials Research · 2000 · 159 citations

, , +15

Determination and Modeling of Kinetics of Cancer Cell Killing by Doxorubicin and Doxorubicin Encapsulated in Targeted Liposomes

Rom E. Eliaz, Shlomo Nir, Cornelia Marty et al. · Cancer Research · 2004 · 151 citations

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study

Mario Masellis, S.Karen Collinson, Natalie Freeman et al. · Brain · 2016 · 61 citations · Full text

, , +15

Robust and prolonged gene expression from injectable polymeric implants

Rom E. Eliaz, Francis C. Szoka · Gene Therapy · 2002 · 54 citations

, , +7

Rows per page

1–5 of 10